Transforming Cancer Care through Genomic Testing

Cancer genomic testing has paved the way for personalized treatment plans, offering more targeted therapies by analyzing the genetic makeup of tumors. Genomic testing identifies specific mutations responsible for cancer growth, helping doctors prescribe the most effective treatments for each patient.

By analyzing a patient’s tumor through techniques like next-generation sequencing (NGS), physicians can detect genetic mutations that guide treatment decisions. Liquid biopsies, which analyze circulating tumor DNA, provide a less invasive way to monitor treatment response and detect emerging resistance, offering a dynamic approach to cancer care.

Genomic testing allows for tailored therapies targeting specific mutations, such as HER2 in breast cancer or BCR-ABL in leukemia. Moreover, the ability to detect genetic signatures has enabled the discovery of new cancer subtypes and improved the repurposing of cancer drugs. Methylation sequencing, a newer tool, helps identify epigenetic changes driving cancer, offering another layer of precision in early cancer detection and treatment.